I've gone from a size 20 to an 8 & lost 8 stone on Mounjaro – I've had hair loss but don't mind, I like my locks thinner
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
A WOMAN has revealed that thanks to Mounjaro, she has lost eight stone and has dropped from a size 20 to an 8.
But Alexandra, 33, who is from the UK and is currently living in Dubai, expressed that since using weight-loss jabs, she has suffered with hair loss.
3
A young woman has revealed that she has slimmed down from a size 20 to an 8 thanks to Mounjaro
Credit: tiktok/@alexandraindubai
3
But although Alexandra loves her new frame, she has also suffered with hair loss
Credit: tiktok/@alexandraindubai
3
Mounjaro is used to treat type 2 diabetes and obesity
Credit: Getty
However, the content creator isn't bothered by this, as she claimed she likes her locks thinner.
Posting on social media, the brunette beauty, who previously revealed the very scary impact stopping Mounjaro had on her body, shared a before and after look at how her figure has changed since using the fat jabs.
In just 12 months, Alexandra confirmed that she lost eight stone, as she wrote: 'What a journey the last year has been. 8 stone lost.'
Alexandra confirmed that during April 2024 to April 2025, she was able to totally transform her life, as she recognised: 'Fat and miserable in the UK to living my best life in Dubai.
'I never would have dreamed life could be this good.'
When asked if she experienced hair loss, the young woman confirmed: 'I did at month four, horrible but no issues now and I like my hair a bit thinner.'
Mounjaro, which is known as the King Kong of jabs, is now being prescribed on the NHS in the first anti-obesity rollout of its kind.
It is said to suppress the appetite, making people feel fuller for longer.
Such injections are licensed for patients with type 2 diabetes and to assist those who are clinically obese - with a Body Mass Index of 30 or over.
One jab is administered each week but the duration is dependent on a person's weight.
Sun Health Explainer: Fat jabs
The drugs can be lawfully supplied only when prescribed by a practitioner - like a doctor, nurse or a pharmacist-independent prescriber.
But many are buying them through online pharmacies with insufficient checks.
Best thing I've ever done!
Alexandra
And just earlier this month, a fat jab warning was issued after more than 100 UK deaths were linked to weight loss drugs.
Not only this, but the family of a man from Burton upon Trent, Staffs, who died after taking Mounjaro, are now calling for a probe into the jab's "potential to kill".
Social media users react
Alexandra's TikTok clip, which was posted under the username @alexandraindubai, has clearly left many open-mouthed, as it has quickly racked up 67,500 views, 3,617 likes and 70 comments.
Social media users were stunned by Alexandra's new figure and many raced to the comments to express this.
One person said: 'You look amazing.'
Another added: 'Wow! That's incredible! Well done you!'
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
A third commented: 'Amazing! You must feel brilliant.'
In response, Alexandra wrote back and shared: 'I feel much better that's for sure!! Thank you!'
Meanwhile, someone else questioned: 'Is it worth it?'
To this, Alexandra confirmed: 'Best thing I've ever done!'
The reality of Mounjaro
But despite Alexandra's weight loss success, last year it was revealed that Scots nurse Susan McGowan, 58, died after taking low-dose injections of Mounjaro over a fortnight.
A probe also found that nearly 400 people have gone to hospital after taking weight loss drugs.
Whilst Alexandra dealt with hair loss, the common side effects include nausea, vomiting and diarrhoea, which can lead to severe dehydration.
What are the other side effects of weight loss jabs?
Like any medication, weight loss jabs can have side effects.
Common side effects of injections such as Ozempic include:
Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts.
Vomiting: Can occur, often in conjunction with nausea.
Diarrhea: Some people experience gastrointestinal upset.
Constipation: Some individuals may also experience constipation.
Stomach pain or discomfort: Some people may experience abdominal pain or discomfort.
Reduced appetite: This is often a desired effect for people using Ozempic for weight loss.
Indigestion: Can cause a feeling of bloating or discomfort after eating.
Serious side effects can also include:
Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting.
Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon.
Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic.
Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic.
Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin.
And if that wasn't bad enough, doctors say they have also seen 'life-threatening complications', including seizures, bowel obstruction and inflammation of the pancreas.
Model Lottie Moss, 27, even said she had a seizure after taking high doses of Ozempic.
The makers of Mounjaro, Lilly UK, said patient safety is its 'top priority'.
Lilly UK stressed: 'Regulatory agencies conduct extensive independent assessments of the benefits and risks of every new medicine and Lilly is committed to continually monitoring, evaluating, and reporting safety data.
'If anyone is experiencing side effects when taking any Lilly medicine, they should talk to their doctor or other healthcare professional.'
Unlock even more award-winning articles as The Sun launches brand new membership programme - Sun Club
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Western Telegraph
39 minutes ago
- Western Telegraph
Health warning as Salmonella cases linked to cheese rise
Salmonella and Campylobacter cases have soared according to the UK Health Security Agency (UKHSA). These infections are usually caught by eating contaminated food such as poultry, meat, eggs, raw fruit and vegetables, as well as unpasteurised milk or cheese. People can die from them via dehydration or if the bacteria enters the bloodstream, which can lead to sepsis — a life-threatening reaction. In response to the surge in cases, the health officials have reminded businesses and households of important food safety measures. Dr Gauri Godbole, Deputy Director, Gastrointestinal infections at UKHSA says: "Our extensive surveillance is showing high levels of gastrointestinal infections in England. We continue to work closely with partners to detect, investigate and halt the spread of infections. "These infections spread in many ways, including through contaminated food or water, contact with an infected person as well as contact with an infected animal or their environment. Washing hands thoroughly with soap and water, particularly after using the toilet or handling raw meat, before meals and after contact with animals or farms can prevent infections. Planning a BBQ this weekend? Food poisoning can easily become an unwelcome guest. Follow good food hygiene practices, such as washing your hands, cooking meat properly, and avoiding cross-contamination. More info on food poisoning: — NHS (@NHSuk) June 20, 2025 "Additionally, anyone experiencing diarrhoea or vomiting should avoid handling or preparing food for others. Do not return to work, and children should not attend school or nursery, until at least 48 hours after symptoms have subsided." Young children, elderly adults and those with weakened immune systems should take extra care as they are at higher risk of developing severe illness. The new data says Campylobacter cases have increased by 17.1% from 60,055 in 2023 to 70,352 in 2024, reaching 121.9 reports per 100,000 population. This represents the highest number of cases recorded in the past decade. Adults aged 50 to 79 years account for 44% of all reports. Similarly, Salmonella infections reached a decade high, with a 17.1% increase from 2023, rising from 8,872 cases in 2023 to 10,388 cases in 2024. Children under 10 years old were particularly affected, accounting for 21.5% of cases. UKHSA and Food Standard Agency (FSA) experts are investigating further with partner agencies to understand the reasons behind this increase in Salmonella and Campylobacter cases. Cases of the parasite Cryptosporidium decreased by 16.4% compared to 2023, with 5,708 cases reported in 2024, although this was the second highest number of cases reported in the past decade. The number of infections in April 2024 were unusually high, associated with large outbreaks linked to lambing events and petting farm venues, and an outbreak in South Devon associated with mains water. The 2023 data for Shiga toxin-producing Escherichia coli (STEC) shows a slight decrease of 2.2% compared to 2022 overall. How do I know if I have food poisoning? All these gastrointestinal infections can cause similar symptoms, including diarrhoea (sometimes bloody), stomach pains and cramps, vomiting and mild fever. While most people recover within one to two weeks of infection, young children, the elderly and those with weakened immune systems face higher risks of developing serious illness or complications. In severe cases, STEC can cause haemolytic uraemic syndrome (HUS), a serious and potentially life-threatening condition primarily affecting the kidneys. Dr James Cooper, Deputy Director of Food Policy at the FSA, says: "Public safety is our highest priority. The FSA works closely with UKHSA and other partners to monitor and assess the latest foodborne disease data. We are working together to understand the reasons behind the rise in Campylobacter and Salmonella cases, as well as trends in other pathogens. This analysis will help us take the necessary action to protect public health. "We've launched a new campaign to help people stay safe - find out more on We're also working with industry and local authorities to support businesses to meet their legal responsibility to make sure food is safe. Consumers can further protect themselves by checking Food Hygiene Ratings on When preparing food at home, people can reduce their risk of food poisoning by following good hygiene practices and by following advice on the 4Cs of food hygiene: chilling, cleaning, cooking, and avoiding cross-contamination. Recommended reading: How can I avoid food poisoning? The FSA has put out this advice. Following good food hygiene and the 4Cs when preparing food can help protect you and others from food poisoning:
The Guardian
2 hours ago
- The Guardian
Ethical questions surround the NHS sampling babies' DNA
Re your report (All babies in England to get DNA test to assess risk of diseases within 10 years, 20 June), the NHS plans to test the DNA of all babies to 'assess disease risk', in association with AI, having already sampled 100,000 newborns. The Department of Health and Social Care said that genomics and AI would be used to 'revolutionise prevention' and provide faster diagnoses and an 'early warning signal for disease'. In line with previous predictions, when individuals who submitted to a PCR test (which amplifies genetic material) during Covid-19 had their DNA sold for profit without their consent, infants now face their private, personal, biological data being captured, stored and used by who-knows-what corporations on behalf of the NHS. Not everyone wants to know what potential diseases they might suffer from in the future, especially if there is no known treatment. And for what purposes might it be used, other than 'prediction of disease risk'? Testing of new drugs? Testing of vaccines? Clearly an infant cannot give consent to its DNA being used for these purposes and research on children is unethical unless they stand to benefit. Will parents have the opportunity to give informed consent and can it even be informed if they are unaware of the many potential uses of the material? A global genomics market of $32.65bn in 2023 suggests that this is big business. Genomics England already makes available patients' genomic data to businesses. The association with AI additionally raises the spectre of surveillance in the form of digital IDs, incorporating not only biometric data, such as fingerprints, retinal scans and facial recognition, but potentially even the human genome itself. The NHS data of 57 million patients has already been used to train AI outside of the intended purpose. Will doctors recognise these risks and take steps to inform patients? Or will technology roll on regardless?Janet MenageRetired GP, Llanybydder, Ceredigion Have an opinion on anything you've read in the Guardian today? Please email us your letter and it will be considered for publication in our letters section.
The Guardian
2 hours ago
- The Guardian
A clear set of actions is needed to improve NHS maternity services
This inquiry (Wes Streeting announces investigation into 'failing' NHS maternity services, 23 June) needs to get to the heart of why NHS maternity services in England are falling far short of where they need to be. It must leave no stone unturned; there are significant, systemic challenges that affect trusts' ability to consistently deliver high-quality care, deep-rooted issues with morale and culture within maternity services and, as you highlight (Editorial, 23 June), the 'shockingly higher risk of mortality faced by black and Asian mothers' and those from more deprived backgrounds. There have been innumerable recommendations and a regulatory landscape that has become complex, distracting and difficult for trusts to navigate. Trust leaders will welcome proposals to introduce one clear set of actions to improve care across every NHS maternity CorderyDeputy chief executive, NHS Providers After a number of years overseeing maternity and perinatal services at regional level, this proposal frustrates me. The inquiry is purely politically motivated and will not add any value to the women, babies and families affected previously or who may be in the future. Multiple strategic transformation programmes have been commissioned and funded. There is nothing new to discover; obstetricians focus on healthy babies, midwives focus on happy mothers. The medical v social models of care make this an impossible divide, not helped by either group frequently failing to listen and respond effectively to women's concerns. Perhaps when there are sufficient staff to work together as a team, and we place the woman at the centre of care and an effective digital infrastructure is in place to support effective communication, instead of focusing on the either/or approach of 'high risk' v 'low risk', we might get PearsonGatley, Cheshire We do not need another review of failing maternity services. The national service development funding (SDF) for maternity services will be cut from £95m in 2024-25 to just £2m in 2025-26. The patriarchy rules and as a consequence misogyny sets the tone for maternity care. Why else would there be gynaecology beds for women experiencing miscarriage, ectopic pregnancy or termination on a postnatal ward?Zoe GreenLondon Although failures in maternity care are of great concern, rather than simply chasing after the evidence of what failures look like and castigating those accused of 'passing the buck', perhaps Wes Streeting should also look at the 10 best performing units to find out what they do and how they achieve success. That might prove informative and more inspirational than (once again) punishing those that GibbsEmeritus professor of inclusive educational psychology and philosophy, Newcastle University Have an opinion on anything you've read in the Guardian today? Please email us your letter and it will be considered for publication in our letters section.
